1. Home
  2. OSK vs ABVX Comparison

OSK vs ABVX Comparison

Compare OSK & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oshkosh Corporation

OSK

Oshkosh Corporation

HOLD

Current Price

$172.22

Market Cap

9.6B

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$117.34

Market Cap

9.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSK
ABVX
Founded
1917
2013
Country
United States
France
Employees
N/A
N/A
Industry
Auto Manufacturing
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OSK
ABVX
Price
$172.22
$117.34
Analyst Decision
Buy
Strong Buy
Analyst Count
14
11
Target Price
$156.71
$130.09
AVG Volume (30 Days)
936.3K
1.5M
Earning Date
01-29-2026
03-23-2026
Dividend Yield
1.40%
N/A
EPS Growth
N/A
N/A
EPS
10.02
N/A
Revenue
$10,422,300,000.00
$6,231,374.00
Revenue This Year
$5.91
$6.80
Revenue Next Year
$6.89
N/A
P/E Ratio
$16.32
N/A
Revenue Growth
N/A
N/A
52 Week Low
$76.82
$4.77
52 Week High
$169.62
$148.83

Technical Indicators

Market Signals
Indicator
OSK
ABVX
Relative Strength Index (RSI) 68.43 N/A
Support Level $136.55 N/A
Resistance Level $169.62 N/A
Average True Range (ATR) 6.30 0.00
MACD 0.93 0.00
Stochastic Oscillator 87.63 0.00

Price Performance

Historical Comparison
OSK
ABVX

About OSK Oshkosh Corporation

Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (49% of revenue), Vocational (31%), and Transport (20%) on 2024 revenue of $10.7 billion.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: